MARKET

THMO

THMO

ThermoGenesis Holdings Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.130
+0.090
+2.96%
Pre Market: 2.940 -0.19 -6.07% 07:00 03/31 EDT
OPEN
3.300
PREV CLOSE
3.040
HIGH
3.320
LOW
2.750
VOLUME
1.57M
TURNOVER
--
52 WEEK HIGH
7.80
52 WEEK LOW
1.630
MARKET CAP
14.28M
P/E (TTM)
-0.9506
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of THMO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average THMO stock price target is 7.50 with a high estimate of 7.50 and a low estimate of 7.50.

EPS

THMO News

More
  • ABT, DD among premarket gainers
  • Seeking Alpha - Article · 22h ago
  • ThermoGenesis Holdings Announces Closing Of $3.5 Million Registered Direct Offering Priced At-the-Market
  • PR Newswire · 3d ago
  • ThermoGenesis launches $3.5M direct offering; shares down 28% premarket
  • seekingalpha · 5d ago
  • TWO, ARI, GOGO and TTOO among midday movers
  • Seeking Alpha - Article · 5d ago

Industry

Office Equipment
+2.74%
Technology Equipment
+2.96%

Hot Stocks

Symbol
Price
%Change

About THMO

ThermoGenesis Holdings, Inc., formerly Cesca Therapeutics Inc., develops, commercializes and markets a range of automated technologies for chimeric antigen receptor (CAR)-T and other cell-based therapies. It offers a suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology. Its CAR-TXpress platform is its cellular processing platform. It offers cell manufacturing tools and services in the global cell and gene therapy market.
More

Webull offers kinds of Thermogenesis Holdings Inc stock information, including NASDAQ:THMO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, THMO stock news, and many more online research tools to help you make informed decisions.